Pathstone Family Office’s Athira Pharma ATHA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | $859K | Hold |
425,492
| – | – | 0.01% | 787 |
|
|
2023
Q2 | $1.26M | Hold |
425,492
| – | – | 0.02% | 415 |
|
|
2023
Q1 | $1.06M | Sell |
425,492
-3,205,588
| -88% | -$8.01M | 0.02% | 424 |
|
|
2022
Q4 | $8.18M | Hold |
3,631,080
| – | – | 0.07% | 200 |
|
|
2022
Q3 | $10.8M | Buy |
3,631,080
+1,942,240
| +115% | +$5.77M | 0.1% | 129 |
|
|
2022
Q2 | $5.15M | Buy |
1,688,840
+59,300
| +4% | +$181K | 0.11% | 101 |
|
|
2022
Q1 | $22M | Buy |
1,629,540
+187,293
| +13% | +$2.53M | 0.51% | 34 |
|
|
2021
Q4 | $18.8M | Buy |
1,442,247
+295,800
| +26% | +$3.85M | 0.47% | 36 |
|
|
2021
Q3 | $10.8M | Buy |
1,146,447
+484,835
| +73% | +$4.55M | 0.31% | 43 |
|
|
2021
Q2 | $6.78M | Buy |
661,612
+162,196
| +32% | +$1.66M | 0.2% | 65 |
|
|
2021
Q1 | $9.19M | Buy |
499,416
+417,533
| +510% | +$7.68M | 0.31% | 49 |
|
|
2020
Q4 | $2.8M | Sell |
81,883
-2,816
| -3% | -$96.4K | 0.12% | 72 |
|
|
2020
Q3 | $1.56M | Buy |
+84,699
| New | +$1.56M | 0.17% | 67 |
|